选填,简要介绍文档的主要内容,方便文档被更多人浏览和下载。
CorrespondenceEleniTholouli1
Ef eLiakopoulou2
HayleyM.Green eld1BronwenE.Shaw3SudhirTauro4
JenniferL.Byrne3MikeDennis2JohnBurthem1GuyS.Lucas1
CharlesCraddock4NigelH.Russell3JohnA.LiuYin1
1
UniversityDepartmentofHaematology,ManchesterRoyalIn rmary,
Manchester,2DepartmentofHaematology,ChristieHospital,Manchester,3DepartmentofHaematology,CityHospital,Nottingham,and4DepartmentofHaematology,UniversityHospitalBirmingham,Birmingham,UK.
E-mail:john.yin@cmmc.nhs.uk
References
Chakraverty,R.,Peggs,K.,Chopra,R.,Milligan,D.W.,Kottaridis,P.D.,Verfuerth,S.,Geary,J.,Thuraisundaram,D.,Branson,K.,Chakrab-arti,S.,Mahendra,P.,Craddock,C.,Parker,A.,Hunter,A.,Hale,G.,Waldmann,H.,Williams,C.D.,Yong,K.,Linch,D.C.,Goldstone,A.H.&Mackinnon,S.(2002)Limitingtransplantation-relatedmor-talityfollowingunrelateddonorstemcelltransplantationbyusinganonmyeloablativeconditioningregimen.Blood,99,1071–1078.Giralt,S.,Thall,P.F.,Khouri,I.,Wang,X.,Braunschweig,I.,Ippolitti,C.,Claxton,D.,Donato,M.,Bruton,J.,Cohen,A.,Davis,M.,Andersson,B.S.,Anderlini,P.,Gajewski,J.,Kornblau,S.,Andreeff,M.,Przepiorka,D.,Ueno,N.T.,Molldrem,J.&Champlin,R.(2001)Melphalanandpurineanalog-containingpreparativeregimens:reduced-intensityconditioningforpatientswithhematologicmalignanciesundergoingallogeneicprogenitorcelltransplantation.Blood,97,631–637.
Kottaridis,P.D.,Milligan,D.W.,Chopra,R.,Chakraverty,R.K.,Chakrabarti,S.,Robinson,S.,Peggs,K.,Verfuerth,S.,Pettengell,R.,Marsh,J.C.,Schey,S.,Mahendra,P.,Morgan,G.J.,Hale,G.,Waldmann,H.,deElvira,M.C.,Williams,C.D.,Devereux,S.,Linch,D.C.,Goldstone,A.H.&Mackinnon,S.(2000)InvivoCAMPATH-
1Hpreventsgraft-versus-hostdiseasefollowingnonmyeloablativestemcelltransplantation.Blood,96,2419–2425.
Marmont,A.M.,Horowitz,M.M.,Gale,R.P.,Sobocinski,K.,Ash,R.C.,vanBekkum,D.W.,Champlin,R.E.,Dicke,K.A.,Goldman,J.M.,Good,R.A.,Herzig,R.H.,Hong,R.,Masaoka,T.,Rimm,A.A.,Ringden,O.,Speck,B.,Weiner,R.S.&Bortin,M.M.(1991)T-celldepletionofHLA-identicaltransplantsinleukemia.Blood,78,2120–2130.
Mitsuyasu,R.T.,Champlin,R.E.,Gale,R.P.,Ho,W.G.,Lenarsky,C.,Winston,D.,Selch,M.,Elashoff,R.,Giorgi,J.V.&Wells,J.(1986)Treatmentofdonorbonemarrowwithmonoclonalanti-T-cellantibodyandcomplementforthepreventionofgraft-versus-hostdisease.Aprospective,randomized,double-blindtrial.AnnalsofInternalMedicine,105,20–26.
Slavin,S.,Nagler,A.,Naparstek,E.,Kapelushnik,Y.,Aker,M.,Civi-dalli,G.,Varadi,G.,Kirschbaum,M.,Ackerstein,A.,Samuel,S.,Amar,A.,Brautbar,C.,Ben-Tal,O.,Eldor,A.&Or,R.(1998)Nonmyeloablativestemcelltransplantationandcelltherapyasanalternativetoconventionalbonemarrowtransplantationwithlethalcytoreductionforthetreatmentofmalignantandnonmalignanthematologicdiseases.Blood,91,756–763.
Tauro,S.,Craddock,C.,Peggs,K.,Begum,G.,Mahendra,P.,Cook,G.,Marsh,J.,Milligan,D.,Goldstone,A.,Hunter,A.,Khwaja,A.,Chopra,R.,Littlewood,T.,Peniket,A.,Parker,A.,Jackson,G.,Hale,G.,Cook,M.,Russell,N.&Mackinnon,S.(2005)Allogeneicstem-celltransplantationusingareduced-intensityconditioningregimenhasthecapacitytoproducedurableremissionsandlong-termdis-ease-freesurvivalinpatientswithhigh-riskacutemyeloidleukemiaandmyelodysplasia.JournalofClinicalOncology,23,9387–9393.Wong,R.,Giralt,S.A.,Martin,T.,Couriel,D.R.,Anagnostopoulos,A.,Hosing,C.,Andersson,B.S.,Cano,P.,Shahjahan,M.,Ippoliti,C.,Estey,E.H.,McMannis,J.,Gajewski,J.L.,Champlin,R.E.&deLima,M.(2003)Reduced-intensityconditioningforunrelateddonorhematopoieticstemcelltransplantationastreatmentformyeloidmalignanciesinpatientsolderthan55years.Blood,102,3052–3059.
Keywords:alemtuzumab,acutemyeloidleukaemia,poorriskmyelodysplasia,reducedintensityconditioning,stemcelltransplant.
Firstpublishedonline19May2008doi:10.1111/j.1365-2141.2008.07184.x
ViralmicroRNApro leinEpstein-Barrvirus-associatedperipheralTcelllymphoma
Epstein-Barrvirus(EBV)infectionhasbeenlinkedtothedevelopmentofavarietyofmalignancies,includingHodgkinlymphoma(HL),nasopharyngealcarcinoma(NPC),Burkittlymphoma(BL),post-transplantationlymphoproliferativedisorder(PTLD)andperipheralTcelllymphoma(PTCL)320
(Thompson&Kurzrock,2004).PTCLoccursinapproxi-mately10%ofallnon-HLsinwesterncountries,andmorefrequentlyinsomepartsofAsiancountriessuchasJapanandKorea(LymphomaStudyGroupofJapanesePathologists.,2000).
ª2008TheAuthors
JournalCompilationª2008BlackwellPublishingLtd,BritishJournalofHaematology,142,308–326
Epstein–Barr virus-encoded microRNA miR-BART2_医学_高等教育_教育专区。... Epstein-Barr Virus LMP... 8页 免费 Epstein-Barr病毒与其相... 4页 ...
Epstein-Barr virus indep... 暂无评价 10页 2财富值 Viral microRNA ...MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular...
2008. Epstein-Barr virus¨ ¨¨ encoded microRNA miR-BART2 down-regulates...Kaposi’s sarcoma-associated herpesvirus expresses an array of viral microRNAs...
transformation of B cell by Epstein-barr virus[J],nature reviews/immunology... regulating cellular ubiquitination processes for maintenance of viral latency[J...
Infection frequency of Epstein-Barr virus in subgingival samples from patients with different pe_专业资料。维普资讯 http://www.cqvip.com 867 Wuea....
3 - 85 MicroRNA Expression Profile of X-ray Irradiated HeLa Cells_专业资料。 今日推荐 88份文档 2014年全国注册造价工程师...
Epstein-Barr virus (EBV) is associated with ...profile: miR-7, miR-9, and miR-155 are ...Quantitative detection of viral gene expression in ...
Epstein-Barr virus-media... 暂无评价 6页 2财富值 Function of microRNA-...36 EST contigs were associated with pathogen infection (Zhang et al. 2005)...
The latent membrane protein-1 encoded by Epstein Barr virus is currently of...2003. Use of adeno-associated viral vector for delivery of small interfering...
Epstein-Barr病毒相关疾病的研究现状_林学_农林牧渔_专业资料 暂无评价0人阅读0次下载举报文档 Epstein-Barr病毒相关疾病的研究现状_林学_农林牧渔_专业资料。...
热门文档